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Clinics and pathology 
Disease 
Chronic myelomonocytic leukemia (CMML) 
Epidemiology 
This is a rare chromosomal rearrangement, only 
reported twice in myeloid hemopathies, without 
molecular characterization but for the case reported by 
Richkind et al. (2000) who showed rearrangement of 
RUNX1 (Secker-Walker et al., 1995; Richkind et al., 
2000). 
Clinics 
A 91-year old woman seen for fever and thrombopenia. 
Cytogenetics 
Note 
The t(20;21)(q13.2;q22.12) involves the RUNX1 (alias 
AML1) gene that acts as an activator or repressor of 
target gene expression depending upon the large 
number of transcription factors, coactivators and 
corepressors that interact with it. RUNX1 functions as 
an organizing protein that facilitates assembly of 
transcriptional activation or repression complexes.  
All the translocations that retain Runt homology  
domain but remove the transcription activation domain 
have a leukemogenic effect by acting as dominant 
negative inhibitors of wild-type RUNX1 in 
transcription activation (De Braekeleer et al., 2011). 
 
RHG banding showing chromosomes 20 and 21 and the 
derivatives der(20) and der(21). 
Cytogenetics morphological 
t(20;21)(q13.2;q22.12) identified by FISH in a clone 
having a trisomy 8 (cryptic rearrangement). 
Cytogenetics molecular 
FISH showed that the breakpoint on 21q22 was located 
in RUNX1. To confirm the position of the breakpoint 
on chromosome 20, BACs located at 20q13 were used 
as probes in FISH experiments. Analysis with RP11-
184L6 showed that one signal hybridized to the normal 
chromosome 20, and the other splitted and hybridized 
to both der(20) and der(21). Co-hybridization with the 
RP11-184L6 clone and a RUNX1 probe (RP11-77G18) 
showed two fusion signals. RP11-184L6 contains the 
ZFP64 gene. 
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FISH with BACs RP11-77G18 (spectrum green, located in 21q22.12 and containing RUNX1) and RP11-184L6 (spectrum orange, located 
in 20q13.2 and containing ZFP64) showing co-hybridization of both derivative chromosomes. 
 





RUNX1 belongs to a family of genes that share a 128 
amino acid region of high sequence homology, known 
as the 'Runt domain', first identified in the Drosophila 
runt gene.  
This 'Runt homology domain' is responsible for 
heterodimerization with the core-binding factor-b 
(CBF-b or PEBP2b) to form a transcription factor and 
for DNA binding.  
RUNX1 acts as a key regulator of hematopoiesis 
through the regulation of various hematopoietic genes, 
including growth factors (GM-CSF, MPO and IL-3), 
surface receptors (TCRA, TCRB, M-CSF receptor and 
FLT3), signaling molecules (CDKN1A, BLK and 
BCL2) and transcription activators (STAT3 and MYB). 
DNA/RNA 
The RUNX1 gene spans 260 kb and consists of 12 
exons with two distinct promoters.  
 
At least 12 different RUNX1 mRNAs differing in their 
types of 5' and 3' untranslated regions (UTRs) and their
coding regions are generated. 
Protein 
The RUNX1 protein contains a 'Runt homology 
domain' as well as transcription activation and 
inhibition domains.  
It acts as an activator or repressor of target gene 
expression depending upon the large number of 
transcription factors, coactivators and corepressors that 
interact with it.  
RUNX1 functions as an organizing protein that 
facilitates assembly of transcriptional activation r
repression complexes.  
By recruitment of non-DNA binding proteins as 
p300/CBP and histone acetyltransferase, it contributes 
to the activation of transcription of target genes.  
Upon recruitment of non-DNA binding repressors such 
as mSin3A, Groucho/TLE and histone deacetylase, it 













Atlas Genet Cytogenet Oncol Haematol. 2013; 17(5)  343 
DNA/RNA 
The ZFP64 gene contains 6 exons spanning 41 kb. 
Twelwe transcripts are known, of which 9 are protein 
coding. 
Protein 
ZFP64 protein belongs to the krueppel C2H2-type zinc-
finger protein family and contains 9 C2H2-type zinc 
fingers.  
It may be involved in transcriptional regulation. It 
interacts with the intracellular domain of Notch1, and 
acts as a coactivator of the Notch intracellular domain 
(Sakamoto et al., 2008). 
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